Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 87523 · Class II · New York Blood Center Inc
Key facts
| Event ID | 87523 |
|---|---|
| Recall numbers | B-0364-2021 |
| Recalling firm | New York Blood Center Inc |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed. |
| Initiation date | Feb 3, 2021 |
| Report date | Apr 7, 2021 |
| Termination date | Mar 30, 2021 |
| City | Saint Paul |
| State | MN |
| Country | United States |
| FEI number | 2170665 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: